Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Current assets:
Cash and cash equivalents	$ 2,634	$ 7,396
Accounts receivable, net	2,297	2,407
Inventories, net	2,849	2,663
Prepaid expenses and other current assets	3,230	3,746
Current portion of deferred consideration, net of discount	222	218
Total current assets	11,232	16,430
Property and equipment, net	314	320
Operating lease, right of use assets	471	559
Deferred tax asset	1,089	829
Deferred consideration, net of discount, less current portion	514	630
Other assets	308	77
Total assets	13,928	18,845
Current liabilities:
Accounts payable	1,302	1,641
Accrued expenses and other current liabilities	2,201	1,843
Deferred revenue	100	1,223
Deferred revenue Invekra	55	54
Current portion of debt-PPP	0	120
Short-term debt	0	688
Operating lease liabilities	276	250
Total current liabilities	3,934	5,819
Long-term deferred revenue Invekra	128	182
Long-term debt	15	0
Withholding tax payable	4,097	3,838
Operating lease liabilities, less current portion	195	309
Total liabilities	8,369	10,148
Stockholders’ Equity:
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at December 31, 2022 and March 31, 2022, respectively, no shares issued and outstanding at December 31, 2022 and March 31, 2022, respectively	0	0
Common stock, $0.0001 par value; 24,000,000 shares authorized at December 31, 2022 and March 31, 2022, respectively, 3,109,652 and 3,100,937 shares issued and outstanding at December 31, 2022 and March 31, 2022, respectively (Note 7)	2	2
Additional paid-in capital	197,939	197,370
Accumulated deficit	(188,206)	(184,363)
Accumulated other comprehensive loss	(4,176)	(4,312)
Total stockholders’ equity	5,559	8,697
Total liabilities and stockholders’ equity	$ 13,928	$ 18,845